Iovance Biotherapeutics stockIOVA
Iovance Biotherapeutics trades at $7.74, 49.6% below its 52-week high (Oct 21, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +183.5% year to date, +327.6% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for IOVA — after you log in
Open the terminalFrequently asked questions about Iovance Biotherapeutics
What is the Iovance Biotherapeutics stock price?
At the close on Nov 5, 2026: $7.74 (−11.03% on the day). 52-week high: $15.37 on Oct 21, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Iovance Biotherapeutics report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed +80% year over year, revenue +80%.
Does Iovance Biotherapeutics pay dividends?
No, Iovance Biotherapeutics does not pay dividends.
Where does Iovance Biotherapeutics trade and how to buy it?
Ticker IOVA, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Iovance Biotherapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for IOVA are in the terminal after you log in.